In line with these and our observations, somatostatin analogs modified with weaker albumin binders such as the 4-(p-chlorophenyl)butanoate or 4-(p-bromophenyl)butanoate entities showed faster tumor accumulation when compared with the analog modified with the 4-(p-iodophenyl)butanoate entity [34]. The gene discussed is SST; the disease is neoplasm.